4
Changes in Ownership
Viking Therapeutics, Inc. Filed Acc 0001209191-19-044336
Options or other derivatives
- VP, Finance and Administration acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MORNEAU MICHAEL VP, Finance and Administration | 2019-07-31 | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…